PT - JOURNAL ARTICLE AU - Alahakoon, Punya AU - McCaw, James M. AU - Taylor, Peter G. TI - Improving estimates of waning immunity rates in stochastic SIRS models with a hierarchical framework AID - 10.1101/2022.09.14.22279950 DP - 2022 Jan 01 TA - medRxiv PG - 2022.09.14.22279950 4099 - http://medrxiv.org/content/early/2022/09/17/2022.09.14.22279950.short 4100 - http://medrxiv.org/content/early/2022/09/17/2022.09.14.22279950.full AB - Most disease pathogens require onward transmission for their continued persistence. It is necessary to have continuous replenishment of the population of susceptibles, either through births, immigration, or waning immunity in recovered individuals.Consider the introduction of an unknown infectious disease into a fully susceptible population where it is not known how long immunity is conferred once an individual recovers. If the disease takes off, the number of infectives will typically decrease to a low level after the first major outbreak. During this period, the disease dynamics will be highly influenced by stochastic effects and there is a non-zero probability that the epidemic will die out. This is known as an epidemic fade-out. If the disease does not die out, the susceptible population may be replenished by the waning of immunity, and a second wave may start.In this study, we describe an experiment where we generated synthetic outbreak data from independent stochastic SIRS models in multiple communities. Some of the outbreaks faded-out and some did not. By conducting Bayesian parameter estimation independently on each outbreak, as well as under a hierarchical framework, we investigated if the waning immunity rate could be correctly identified. When the outbreaks were considered independently, the waning immunity rate was incorrectly estimated when an epidemic fade-out was observed. However, the hierarchical approach improved the parameter estimates. This was particularly the case for those communities where the epidemic faded out.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPunya Alahakoon is supported by a Melbourne Research Scholarship from the University of Melbourne. P.G. Taylor would like to acknowledge the support of the Australian Research Council via the Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data synthetic data and relevant details included (including the URL) can be found in the Supplementary Material.